Highlights Beyond Air, Inc.

Equities

XAIR

US08862L1035

Delayed Nasdaq Other stock markets 12:35:46 2024-05-21 pm EDT			5-day change	1st Jan Change
1.31 ^USD	0.00%		+14.47%	-33.42%

Apr. 30	Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating	MT
Feb. 12	Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year 2025	Feb. 12	CI
Earnings Flash (XAIR) BEYOND AIR Posts Q3 Revenue $391,000, vs. Street Est of $0.45M	Feb. 12	MT
Beyond Air, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 13	CI
Earnings Flash (XAIR) BEYOND AIR Reports Q2 Revenue $239,000, vs. Street Est of $482,000	Nov. 13	MT
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year Ending March 31, 2025	Nov. 13	CI
Beyond Air, Inc. Receives Innovative Technology Contract from Vizient for LungFit PH	23-10-16	CI
EARNINGS: Andrews Sykes revenue up; Safestay optimistic	23-09-26	AN
Beyond Air, Inc. Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder	23-09-18	CI
Beyond Air, Inc. and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region	23-09-07	CI
Beyond Air, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Earnings Flash (XAIR) BEYOND AIR Posts Q1 Revenue $59,000, vs. Street Est of $0.34M	23-08-10	MT
Beyond Air, Inc. Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder	23-08-07	CI
Beyond Air, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-23	CI
Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-10	CI
Beyond Air, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-08	CI
Beyond Air® Announces Positive Data for Inhaled Nitric Oxide (NO) to Treat COVOD-19 with LungFit® PRO in A Poster Presentation At IDWeek 2022	22-10-24	CI
Beyond Air Reports 'Positive' Data From LungFit GO Trial of Nontuberculous Mycobacteria Lung Disease	22-10-17	MT
Beyond Air, Inc. Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) Using the LungFit® GO at the CHEST Annual Meeting 2022	22-10-17	CI
Beyond Air Announces Annals of the American Thoracic Society Published Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis	22-10-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Beyond Air, Inc.

Equities

XAIR

US08862L1035

Highlights

Filters